European Archives - Page 79 of 1111 - European Medical Journal

Diabetes Medications May Reduce COPD Exacerbation Risk, Study Finds

SGLT-2is and GLP-1RAs linked to lower COPD exacerbation risk in T2D patients, study finds.

Navigating Antimicrobial Resistance: Interview with Timothy Walsh

We discovered NDM-1, which stands for New Delhi metallo-beta-lactamase, at the end of 2009, but nobody cared about it too much at the time…

Single-Cell Study Reveals How the Immune System Evolves from Birth to Old Age

New research maps immune system changes across the human lifespan, revealing key insights into aging and health.

New Model Improves Early Detection of Lymph Node Metastasis in Breast Cancer

New model enhances early detection of lymph node metastasis in breast cancer using CEUS images and machine learning.

Air Pollution Exposure Linked to Liver Inflammation and Fatty Liver Disease

Even low levels of air pollution can cause liver inflammation, fibrosis, and metabolic changes linked to fatty liver disease.

Salt Substitute Cuts Stroke Risk and Mortality in Major Clinical Trial

Replacing regular salt with a reduced-sodium, added-potassium substitute significantly lowered recurrent stroke and mortality risk in stroke patients.

Avacopan Shows Promise for ANCA-Associated Vasculitis Despite High Discontinuation Rates

A new Japanese retrospective study confirms that avacopan can effectively induce and sustain remission in patients with ANCA-associated vasculitis, reducing the need for glucocorticoids.

Abortion Bans Linked to 5.6% Increase in Infant Mortality in the USA

A new study has found that infant mortality rates have increased in US states that enacted abortion bans, with Black infants, those with congenital anomalies, and those in southern states facing the highest risks.

Faecal Microbiota Transplantation: A New Era for C. difficile Treatment

A new systematic review and network meta-analysis confirms that faecal microbiota transplantation is the most effective treatment for Clostridioides difficile infection.

Personalized IgG-Based Elimination Diet Reduces IBS Symptoms in New Trial

A groundbreaking multicenter clinical trial has found that a personalized elimination diet guided by an IBS-specific IgG antibody assay significantly reduces abdominal pain intensity and symptoms in IBS patients.